|
Mamyzin
Injection provides a convenient and effective treatment for
mastitis caused by penicillin sensitive organisms. It provides
persistent and high levels of bacteriocidal penicillin to all 4
quarters following daily intramuscular injections maintaining
antibacterial effects over a 4 day course of treatment.
Not only does Mamyzin effectively treat clinical mastitis but it is
also effective in the treatment of sub-clinical disease caused by these
same organisms whether occurring alone or concurrently in adjacent
quarters to those affected clinically. It is also effective in the
treatment of dry cows and heifers providing benefits in the ensuing
lactation.
|
|
Boehringer
Ingelheim Ltd is one of the UK's most innovative pharmaceutical
companies. We are part of the Boehringer Ingelheim group of companies,
which specialise in human pharmaceuticals and animal health. The group
is dedicated to researching, developing, manufacturing and marketing a
range of leading products for patients throughout the world.
Our UK offices are in Bracknell, Berkshire and our corporate headquarters are in Ingelheim, Germany.
Once
again Boehringer Ingelheim has been judged as one of the top 100
companies in the Sunday Times Best Companies to Work For competition.
This year we maintained our top twenty position, having been awarded
19th best company in the UK. Yet again Boehringer Ingelheim is the
highest ranked pharmaceutical company.
For further information about Boehringer Ingelheim please click the link for the corporate website
|
